Device
Adaptive Servo Ventilation
Adaptive Servo Ventilation is a medical device with 3 clinical trials. Historical success rate of 33.3%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
33.3%
Based on 1 completed trials
Completion Rate
33%(1/3)
Active Trials
0(0%)
Results Posted
100%(1 trials)
Terminated
2(67%)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
33.3%
1 of 3 finished
Non-Completion Rate
66.7%
2 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Terminated(2)
Detailed Status
Terminated2
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
33.3%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
completed133%
terminated267%
Recent Activity
0 active trials
Showing 3 of 3
terminatednot_applicable
Effect of Adaptive Servo Ventilation (ASV) on Survival and Hospital Admissions in Heart Failure
NCT01128816
terminatednot_applicable
The Role of Sleep Disordered Breathing in Heart Failure Admissions
NCT02505867
completednot_applicable
The Effect of Adaptive Servo Ventilation and Oxygen Therapy in Central Sleep Apnea Patients
NCT01187823
Clinical Trials (3)
Showing 3 of 3 trials
NCT01128816Not Applicable
Effect of Adaptive Servo Ventilation (ASV) on Survival and Hospital Admissions in Heart Failure
NCT02505867Not Applicable
The Role of Sleep Disordered Breathing in Heart Failure Admissions
NCT01187823Not Applicable
The Effect of Adaptive Servo Ventilation and Oxygen Therapy in Central Sleep Apnea Patients
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3